Colazal News
Salix Pharma Posts Q4 Loss; Revenue Down - Update - RTT News
The latest period included a $34.6 million non-cash charge associated with the introduction of generic competitors to Salix's COLAZAL. ...
Generic Competition Cuts Deeply into Profits, Salix Says - WRAL.com
The generics led Salix to take a write off in potential profits for its drug Colazal. However, Salix did report $2.2 million sales for its own generic ...
Salix reports $19 million loss - News & Observer
The drug, Colazal, is used to treat ulcerative colitis. Federal regulators in December approved generic versions of the drug, which are cheaper for patients ...
$19 million loss at Salix; generics blamed - News & Observer
The main factor contributing to the loss was a $34.6 million charge to account for generic competition to Colazal, a gastrointestinal treatment that is the ...
Salix Pharma swings to 4Q loss, revenue declines - CNNMoney.com
The company said it recorded a $34.6 million charge during the fourth quarter related to the introduction of generic competitors to its Colazal, ...
Salix Pharmaceuticals "neutral," target price reduced - newratings.com
The significant rise in spending is likely to offset the impact of the termination of the Eisai co-promotion and the launch of the 1100mg Colazal in 2H08 ...
Generic charge pushes Salix into red - Bizjournals.com
... US regulators approved three companies' applications to sell generic versions of the company's best-selling treatment, ulcerative colitis drug Colazal. ...
Salix shares fall on 4Q loss, outlook - BusinessWeek
Excluding a $34.6 million charge related to generic competition over the ulcerative colitis drug Colazal, the company earned 32 cents per share on revenue ...
Market Report -- Short Stories (SLXP) - MSN Money
Credit Suisse initiates SLXP with a Neutral and a $7 tgt saying they view generic Colazal as an obvious setback and now look to 2008 as a transition year ...
Shares slip after Salix warns of losses - San Antonio Business Journal
The announcement came after US regulators approved three companies' applications to sell generic versions of Salix's best-selling treatment, Colazal, ...
Colazal RSS Feed